Gain Therapeutics Stock Widgets and Gadgets
| GANX Stock | USD 1.73 0.09 4.95% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- GANX Gain Therapeutics
- Latest Gain Therapeutics shares hold Buy rating H.C. Wainwright optimistic on GT-02287 clinical data
- GANX 1.73 -0.09
- Low 1.72
- High 1.85
- Alpha 0.52
- Beta 1.08
- Return On Equity -1.89
- Return On Asset -0.73
- Current Valuation 34.61 M
- Shares Outstanding 26.53 M
- Shares Owned By Insiders 5.09 %
- Shares Owned By Institutions 7.96 %
- Number Of Shares Shorted 658.34 K
- Price To Book 5.15 X
- Price To Sales 925.92 X
- Revenue 55.18 K
- Gross Profit (7.66 M)
- EBITDA (22.17 M)
- Net Income (22.27 M)
- Cash And Equivalents 24.25 M
- Cash Per Share 2.04 X
- Total Debt 1.03 M
- Debt To Equity 0.05 %
- Current Ratio 7.58 X
- Book Value Per Share 0.78 X
- Cash Flow From Operations (18.87 M)
- Short Ratio 1.65 X
- Earnings Per Share (1.07) X
- Target Price 7.4
- Number Of Employees 29
- Beta 0.34
- Market Capitalization 45.89 M
- Total Asset 18.61 M
- Retained Earnings (60.78 M)
- Working Capital 12.83 M
- Net Asset 18.61 M
- Accumulation Distribution 0.0703
- Daily Balance Of Power (0.69)
- Rate Of Daily Change 0.95
- Day Median Price 1.79
- Day Typical Price 1.77
- Market Facilitation Index 0.13
- Price Action Indicator (0.10)
- Period Momentum Indicator (0.09)
- Relative Strength Index 47.17
Market Snapshot Widget Example
DAX Index Germany | 19,296 0.56 | |
Taiwan Weighted Taiwan | 22,679 1.17 | |
PSI 20 Stock Portugal | 6,415 0.36 | |
CROBEX Croatia | 3,142 0.56 | |
Budapest SE Hungary | 80,056 0.74 | |
IDX 30 Jakarta Indonesia | 451.91 1.48 | |
ISEQ 20 Price Ireland | 1,610 0.3 | |
NYSE Comp USA | 20,219 0.0045 | |
Tel Aviv 35 Israel | 2,303 0.97 | |
Coreshares Index Tracker South Afric | 1,095 0.45 | |
IPC MEXICO Mexico | 49,713 1.44 | |
KL Technology Malaysia | 59.58 1.23 | |
IBEX 35 Index Spain | 11,618 0.8 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,518 0.7 | |
SPASX Dividend Opportunities Australia | 1,681 0.93 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,209 0.38 | |
AMS Small Cap Netherlands | 1,166 1.84 | |
Oslo Exchange Mutual Norway | 1,407 1.3 | |
BEL Small Belgium | 8,051 1.19 | |
Basic Materials Brazil | 5,726 0.95 | |
Swiss Leader Price Switzerland | 1,920 0.53 | |
Fondo Mutuo ETF Chile | 1,365 0.25 | |
Athens General Comp Greece | 1,408 0.13 | |
Stock Exchange Of Thailand | 1,438 0.35 | |
PX Prague Stock Czech Repub | 1,679 1.05 | |
THE PHILIPPINE STOCK Philippines | 6,807 0.63 | |
WIG 30 Poland | 2,822 0.14 | |
BIST Electricity Turkey | 493.15 0.1 |
Investing Ideas
In addition to having Gain Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Gain Therapeutics
Compare Gain Therapeutics To Peers
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.